SCHEMBL3395407

SCHEMBL3395407

Cc1cc(C#N)ccc1-c1nc(N(C)c2cc(-c3ccccc3)[nH]n2)ncc1C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.40
CYP19A1 P11511 1/20 0.34
LRRK2 Q5S007 2/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
EGLN2 Q96KS0 3/20 0.32
S1PR1 P21453 1/20 0.32
TNIK Q9UKE5 1/20 0.32
CYP1A2 P05177 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
OXTR P30559 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3434435 0.90 KCNH2 (0.33) KCNH2CYP19A1LRRK2GSK3AGSK3B
SCHEMBL3394362 0.86 PTGES (0.37) GSK3AGSK3BCYP1A2HSD17B10
SCHEMBL3433177 0.80 KCNH2 (0.36) KCNH2CYP19A1LRRK2GSK3AGSK3B
SCHEMBL3395404 0.77 KCNH2 (0.47) KCNH2LRRK2GSK3AGSK3BCYP1A2
SCHEMBL3392275 0.75 KCNH2 (0.46) KCNH2LRRK2EGLN2OXTR
SCHEMBL3434686 0.72 KCNH2 (0.44) KCNH2CYP19A1LRRK2GSK3AGSK3B
SCHEMBL3432960 0.72 KCNH2 (0.43) KCNH2CYP19A1LRRK2EGLN2TNIK
Hydrochloric Acid SCHEMBL3395604 0.72 KCNH2 (0.43) KCNH2CYP19A1LRRK2GSK3AGSK3B
SCHEMBL3393481 0.72 MAPT (0.38) LRRK2S1PR1TNIKCASP1CASP7
Hydrochloric Acid SCHEMBL3432843 0.71 KCNH2 (0.42) KCNH2LRRK2EGLN2TNIKCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed